To explore the aggregation and seeding potential of the GzmA-cleaved tau fragments, an established protocol [16,35] using as ‘seed’ the SI fraction from CBD or PSP brain (in which aggregated C-terminal tau fragments are abundant [36,37]) was employed (Figure 4A). The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.